Asia-Pacific Emerges as a High-Growth Hub in Toxicology Drug Screening: Rising Healthcare Spending, Pharma Expansion, and Local Regulatory Shifts
The Asia-Pacific region is rapidly emerging as a key growth hub for the toxicology drug screening market, with demand projected to grow at a 10.5% CAGR from 2024–2030. This expansion is driven by three factors: rising healthcare spending, a surge in pharmaceutical R&D, and evolving regulatory frameworks that prioritize drug safety. Countries like China, India, and South Korea lead the...
0 Commenti
0 condivisioni
828 Views